CAR-T Cells: The Next Era in Immuno-Oncology – AJMC.com Managed Markets Network
|
CAR–T Cells: The Next Era in Immuno-Oncology
AJMC.com Managed Markets Network We believe the next I-O frontier to move from the bench to the bedside is cellular therapy in the form of chimeric antigen receptor (CAR)-T cells. In the first published trial from the University of Pennsylvania (U-Penn), 27 of 30 (90%) relapsed and … |
